Request TOC and Sample - Rat Model Market by Model Type (Outbred Rats, Inbred Rats, Genetically Modified Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, Immunodeficient Rats), by Therapeutic Area (Toxicology, Oncology, Diabetes, Neurology, Immunology and Inflammation, Other Therapeutic Areas), by Application (Breeding, Rederivation, Cryopreservation, Quarantine, Model-in-Licensing, Genetic Testing, Others), by Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies) and by End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)): Global Opportunity Analysis and Industry Forecast, 2023-2032

Rat Model Market, by Model Type (Outbred Rats, Inbred Rats, Genetically Modified Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, Immunodeficient Rats), by Therapeutic Area (Toxicology, Oncology, Diabetes, Neurology, Immunology and Inflammation, Other Therapeutic Areas), by Application (Breeding, Rederivation, Cryopreservation, Quarantine, Model-in-Licensing, Genetic Testing, Others), by Technology (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies) and, by End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Contract Research Organizations (CROs)): Global Opportunity Analysis and Industry Forecast, 2023-2032